A citation-based method for searching scientific literature

Donna Milne, Amelia Hyatt, Alex Billett, Karla Gough, Mei Krishnasamy. Cancer Nurs 2020
Times Cited: 6







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma.
Dirk Schadendorf, F Stephen Hodi, Caroline Robert, Jeffrey S Weber, Kim Margolin, Omid Hamid, Debra Patt, Tai-Tsang Chen, David M Berman, Jedd D Wolchok. J Clin Oncol 2015
33


Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
33

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn,[...]. Lancet 2016
33

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
33


Effects of enhanced caregiver training program on cancer caregiver's self-efficacy, preparedness, and psychological well-being.
Cristina C Hendrix, Donald E Bailey, Karen E Steinhauser, Maren K Olsen, Karen M Stechuchak, Sarah G Lowman, Abby J Schwartz, Richard F Riedel, Francis J Keefe, Laura S Porter,[...]. Support Care Cancer 2016
69
33

Factors contributing to economic burden in lung cancer spousal caregivers.
Melinda Kavanaugh, Betty J Kramer, Matthew Cunningham Walsh, Amy Trentham-Dietz. Palliat Support Care 2015
13
33

Objective burden, resources, and other stressors among informal cancer caregivers: a hidden quality issue?
Michelle van Ryn, Sara Sanders, Katherine Kahn, Courtney van Houtven, Joan M Griffin, Michelle Martin, Audie A Atienza, Sean Phelan, Deborah Finstad, Julia Rowland. Psychooncology 2011
238
33


Economic burden for informal caregivers of lung and colorectal cancer patients.
Courtney Harold Van Houtven, Scott D Ramsey, Mark C Hornbrook, Audie A Atienza, Michelle van Ryn. Oncologist 2010
98
33

The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481].
Amy P Abernethy, Tania Shelby-James, Belinda S Fazekas, David Woods, David C Currow. BMC Palliat Care 2005
278
16

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.
Paul A Harris, Robert Taylor, Robert Thielke, Jonathon Payne, Nathaniel Gonzalez, Jose G Conde. J Biomed Inform 2009
16

Australian Association for Exercise and Sport Science position stand: optimising cancer outcomes through exercise.
Sandra C Hayes, Rosalind R Spence, Daniel A Galvão, Robert U Newton. J Sci Med Sport 2009
164
16

A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability.
Judith Lacey, Anna J Lomax, Catriona McNeil, Michael Marthick, David Levy, Steven Kao, Theresa Nielsen, Haryana M Dhillon. Support Care Cancer 2019
10
16

Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review.
Wendy H Oldenmenger, Pleun J de Raaf, Cora de Klerk, Carin C D van der Rijt. J Pain Symptom Manage 2013
158
16

Linking fatigue measures on a common reporting metric.
Jin-Shei Lai, David Cella, Betina Yanez, Arthur Stone. J Pain Symptom Manage 2014
31
16

Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok. Science 2018
16

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
16

The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects.
Prue Cormie, Eva M Zopf, Xiaochen Zhang, Kathryn H Schmitz. Epidemiol Rev 2017
254
16

Moderate-intensity exercise reduces fatigue and improves mobility in cancer survivors: a systematic review and meta-regression.
Amy M Dennett, Casey L Peiris, Nora Shields, Luke A Prendergast, Nicholas F Taylor. J Physiother 2016
81
16


Bench-to-Bedside Approaches for Personalized Exercise Therapy in Cancer.
Lee W Jones, Neil D Eves, Jessica M Scott. Am Soc Clin Oncol Educ Book 2017
21
16



SF-36 health survey update.
J E Ware. Spine (Phila Pa 1976) 2000
16

Guidance for using pilot studies to inform the design of intervention trials with continuous outcomes.
Melanie L Bell, Amy L Whitehead, Steven A Julious. Clin Epidemiol 2018
60
16

The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory.
T R Mendoza, X S Wang, C S Cleeland, M Morrissey, B A Johnson, J K Wendt, S L Huber. Cancer 1999
16

Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative.
Sofia F Garcia, David Cella, Steven B Clauser, Kathryn E Flynn, Thomas Lad, Jin-Shei Lai, Bryce B Reeve, Ashley Wilder Smith, Arthur A Stone, Kevin Weinfurt. J Clin Oncol 2007
279
16

CONSORT 2010 statement: extension to randomised pilot and feasibility trials.
Sandra M Eldridge, Claire L Chan, Michael J Campbell, Christine M Bond, Sally Hopewell, Lehana Thabane, Gillian A Lancaster. Pilot Feasibility Stud 2016
454
16

Adolescents and young adult cancer survivors: exercise habits, quality of life and physical activity preferences.
A Murnane, K Gough, K Thompson, L Holland, R Conyers. Support Care Cancer 2015
54
16


Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C Lance Cowey, Christopher D Lao, Dirk Schadendorf, Reinhard Dummer, Michael Smylie, Piotr Rutkowski,[...]. N Engl J Med 2015
16


Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
Luis Paz-Ares, Alexander Luft, David Vicente, Ali Tafreshi, Mahmut Gümüş, Julien Mazières, Barbara Hermes, Filiz Çay Şenler, Tibor Csőszi, Andrea Fülöp,[...]. N Engl J Med 2018
16

Opportunities and challenges in leveraging electronic health record data in oncology.
Marc L Berger, Melissa D Curtis, Gregory Smith, James Harnett, Amy P Abernethy. Future Oncol 2016
63
16

Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy.
Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J Philip, Jo Ann Hsu, Nazli Dizman, Ulka Vaishampayan, Tanya Dorff, Sumanta Kumar Pal. J Immunother Cancer 2019
11
16

Immunotherapy: hype and hope.
The Lancet Oncology. Lancet Oncol 2018
14
16

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Tony S K Mok, Yi-Long Wu, Iveta Kudaba, Dariusz M Kowalski, Byoung Chul Cho, Hande Z Turna, Gilberto Castro, Vichien Srimuninnimit, Konstantin K Laktionov, Igor Bondarenko,[...]. Lancet 2019
16

Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.
Sean Khozin, Amy P Abernethy, Nathan C Nussbaum, Jizu Zhi, Melissa D Curtis, Melisa Tucker, Shannon E Lee, David E Light, Anala Gossai, Rachael A Sorg,[...]. Oncologist 2018
71
16

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
Erik von Elm, Douglas G Altman, Matthias Egger, Stuart J Pocock, Peter C Gøtzsche, Jan P Vandenbroucke. BMJ 2007
16

Comorbidity measures for use with administrative data.
A Elixhauser, C Steiner, D R Harris, R M Coffey. Med Care 1998
16

Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer.
Sandra D Griffith, Melisa Tucker, Bryan Bowser, Geoffrey Calkins, Che-Hsu Joe Chang, Ellie Guardino, Sean Khozin, Josh Kraut, Paul You, Deb Schrag,[...]. Adv Ther 2019
65
16

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.
Hossein Borghaei, Corey J Langer, Shirish Gadgeel, Vassiliki A Papadimitrakopoulou, Amita Patnaik, Steven F Powell, Ryan D Gentzler, Renato G Martins, James P Stevenson, Shadia I Jalal,[...]. J Thorac Oncol 2019
144
16

Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.
Carolyn J Presley, Daiwei Tang, Pamela R Soulos, Anne C Chiang, Janina A Longtine, Kerin B Adelson, Roy S Herbst, Weiwei Zhu, Nathan C Nussbaum, Rachael A Sorg,[...]. JAMA 2018
73
16

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
Mark A Socinski, Robert M Jotte, Federico Cappuzzo, Francisco Orlandi, Daniil Stroyakovskiy, Naoyuki Nogami, Delvys Rodríguez-Abreu, Denis Moro-Sibilot, Christian A Thomas, Fabrice Barlesi,[...]. N Engl J Med 2018
16

First-line systemic therapy practice patterns and concordance with NCCN guidelines for patients diagnosed with metastatic NSCLC treated at NCCN institutions.
Carrie Zornosa, Jonathan L Vandergrift, Gregory P Kalemkerian, David S Ettinger, Michael S Rabin, Mary Reid, Gregory A Otterson, Marianna Koczywas, Thomas A D'Amico, Joyce C Niland,[...]. J Natl Compr Canc Netw 2012
23
16

Lung cancer in the era of precision medicine.
Katerina Politi, Roy S Herbst. Clin Cancer Res 2015
97
16

Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials.
Jeremy M O'Connor, Kristen L Fessele, Jean Steiner, Kathi Seidl-Rathkopf, Kenneth R Carson, Nathan C Nussbaum, Emily S Yin, Kerin B Adelson, Carolyn J Presley, Anne C Chiang,[...]. JAMA Oncol 2018
62
16

Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval.
Sean Khozin, Kenneth R Carson, Jizu Zhi, Melisa Tucker, Shannon E Lee, David E Light, Melissa D Curtis, Marta Bralic, Irene Kaganman, Anala Gossai,[...]. Oncologist 2019
45
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.